Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a Korean "분기보고서" covering the period January 1, 2026 to March 31, 2026 for a listed company (BC World Pharm). It contains comprehensive interim financial and business details rather than just highlights or an announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-05-07 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a ‘주식등의 대량보유상황보고서’ (report on large shareholdings) with corrections (정정신고) describing detailed holdings and changes in share ownership by insiders. It reports threshold-crossing shareholdings under capital markets regulations. This fits the definition of Major Shareholding Notification (MRQ) rather than an earnings release, annual report, or board change. Hence, it should be classified as MRQ.
2026-04-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean "Report on Large Holdings of Stocks (General)" filed under the Capital Market Act, detailing substantial shareholding positions, changes in ownership percentages, related persons, and change reasons. This corresponds to a Major Shareholding Notification (MRQ) rather than an earnings release, annual report, or other regulatory filings. Hence, the correct classification is MRQ.
2026-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a report titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing the ownership status and changes in securities holdings of a company director (이승철). It includes the director’s personal shareholding amounts, acquisition and disposal events, dates of changes, and confirms that this is an insider transaction report filed with the Financial Services Commission and the Korea Exchange. This matches the definition for Director's Dealing (insider share transactions) under our taxonomy.
2026-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Report on Officers and Major Shareholders’ Ownership of Specified Securities). It details the shareholdings and changes (e.g., stock dividends) of an executive (홍영기) and other insiders. This is a mandatory insider transaction/ownership disclosure by directors and major shareholders, matching our “Director’s Dealing” category. It is not a general annual or interim report, nor an M&A or voting announcement, but rather a personal securities transaction and holding report by an officer. Thus, it should be classified as DIRS.
2026-04-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.